It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileAMS’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish while AMS’s TA Score has 6 bullish TA indicator(s).
AMED (@Hospital/Nursing Management) experienced а +0.05% price change this week, while AMS (@Hospital/Nursing Management) price change was +3.06% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.78%. For the same industry, the average monthly price growth was +0.43%, and the average quarterly price growth was +6.39%.
AMED is expected to report earnings on Oct 29, 2025.
AMS is expected to report earnings on Nov 12, 2025.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
AMED | AMS | AMED / AMS | |
Capitalization | 3.32B | 16.9M | 19,651% |
EBITDA | 239M | 7.85M | 3,043% |
Gain YTD | 11.235 | -17.868 | -63% |
P/E Ratio | 39.30 | 12.31 | 319% |
Revenue | 2.4B | 29.2M | 8,226% |
Total Cash | 337M | 11.2M | 3,009% |
Total Debt | 451M | 28M | 1,611% |
AMED | AMS | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 55 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 75 | |
SMR RATING 1..100 | 79 | 81 | |
PRICE GROWTH RATING 1..100 | 51 | 59 | |
P/E GROWTH RATING 1..100 | 36 | 97 | |
SEASONALITY SCORE 1..100 | 39 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS's Valuation (55) in the Medical Or Nursing Services industry is in the same range as AMED (78). This means that AMS’s stock grew similarly to AMED’s over the last 12 months.
AMS's Profit vs Risk Rating (75) in the Medical Or Nursing Services industry is in the same range as AMED (100). This means that AMS’s stock grew similarly to AMED’s over the last 12 months.
AMED's SMR Rating (79) in the Medical Or Nursing Services industry is in the same range as AMS (81). This means that AMED’s stock grew similarly to AMS’s over the last 12 months.
AMED's Price Growth Rating (51) in the Medical Or Nursing Services industry is in the same range as AMS (59). This means that AMED’s stock grew similarly to AMS’s over the last 12 months.
AMED's P/E Growth Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for AMS (97). This means that AMED’s stock grew somewhat faster than AMS’s over the last 12 months.
AMED | AMS | |
---|---|---|
RSI ODDS (%) | 3 days ago33% | N/A |
Stochastic ODDS (%) | 3 days ago51% | 3 days ago80% |
Momentum ODDS (%) | 3 days ago44% | 3 days ago77% |
MACD ODDS (%) | 3 days ago37% | 3 days ago86% |
TrendWeek ODDS (%) | 3 days ago44% | 3 days ago76% |
TrendMonth ODDS (%) | 3 days ago35% | 3 days ago76% |
Advances ODDS (%) | 4 days ago47% | 3 days ago72% |
Declines ODDS (%) | 17 days ago58% | 17 days ago64% |
BollingerBands ODDS (%) | 3 days ago53% | 3 days ago67% |
Aroon ODDS (%) | 3 days ago28% | N/A |
A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.
Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
---|---|---|---|---|
AMED | 100% | N/A | ||
FMCQF - AMED | 24% Poorly correlated | -0.11% | ||
OPCH - AMED | 23% Poorly correlated | -0.32% | ||
EHAB - AMED | 21% Poorly correlated | +2.30% | ||
USPH - AMED | 21% Poorly correlated | -0.23% | ||
BKD - AMED | 20% Poorly correlated | -0.27% | ||
More |
A.I.dvisor tells us that AMS and FMS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and FMS's prices will move in lockstep.
Ticker / NAME | Correlation To AMS | 1D Price Change % | ||
---|---|---|---|---|
AMS | 100% | +1.35% | ||
FMS - AMS | 21% Poorly correlated | +0.84% | ||
EHC - AMS | 20% Poorly correlated | +0.61% | ||
CCM - AMS | 6% Poorly correlated | -1.89% | ||
HCSG - AMS | 4% Poorly correlated | -0.46% | ||
AMED - AMS | 1% Poorly correlated | N/A | ||
More |